EastPharma Ltd. reported consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported revenue of USD 124,302,745 compared to USD 112,857,085 reported a year ago. Profit before tax was USD 18,642,114 compared to USD 9,689,053 reported a year ago. Net profit for the period attributable to equity holders of the parent was USD 12,722,719 or USD 0.19 per basic and diluted share compared to USD 6,321,661 or USD 0.093 per basic and diluted share reported a year ago. Net cash provided by operating activities was USD 30,490,213 compared to net cash provided by operating activities of USD 21,417,971 reported a year ago. Purchase of property, plant and equipment was USD 6,970,303 compared to USD 4,396,952 reported a year ago. Purchase of intangible assets was USD 9,109,577 compared to USD 8,309,247 reported a year ago.